Enterovirus D68 receptor requirements unveiled by haploid genetics

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 5, 2016, Pages 1399-1404

  Baggen, Jim ^a   Thibaut, Hendrik Jan ^a   Staring, Jacqueline ^b   Jae, Lucas T ^b   Liu, Yue ^c   Guo, Hongbo ^a   Slager, Jasper J ^a   De Bruin, Jost W ^a   Van Vliet, Arno L W ^a   Blomen, Vincent A ^b   Overduin, Pieter ^d   Sheng, Ju ^c   De Haan Xander, Cornelis A M ^a   De Vries, Erik ^a   Meijer, Adam ^d   Rossmann, Michael G ^c   Brummelkamp, Thijn R ^b,e   Van Kuppeveld, Frank J M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c PURDUE UNIVERSITY   (United States)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e Cancer Genomics Centre   (Netherlands)

Author keywords

Enterovirus D68; Haploid genetic screen; Receptor; Sialic acid

Indexed keywords

ACYLNEURAMINATE CYTIDYLYLTRANSFERASE; BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE; BETA N ACETYLGLUCOSAMINYLGLYCOPEPTIDE BETA 1,4 GALACTOSYLTRANSFERASE; DECAY ACCELERATING FACTOR; ENTEROVIRUS D68 RECEPTOR; GLYCOSYLTRANSFERASE; HOST FACTOR; N ACETYLGLUCOSAMINE; N ACETYLNEURAMINIC ACID; SIALIC ACID; SOLUTE CARRIER FAMILY 35 MEMBER A1; SOLUTE CARRIER FAMILY 35 MEMBER A2; ST6 BETAGALACTOSAMIDE ALPHA 2,6 SIALYLTRANFERASE 1; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOSE; VIRUS RECEPTOR;

ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; CONJUGATION; CONTROLLED STUDY; ENTEROVIRUS; ENTEROVIRUS D68; ENTEROVIRUS INFECTION; ERYTHROCYTE; FLACCID PARALYSIS; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HAPLOIDY; HEMORRHAGIC CONJUNCTIVITIS; HUMAN; HUMAN CELL; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR BINDING; RESPIRATORY TRACT INFECTION; TROPISM; ANIMAL; CELL LINE; ENTEROVIRUS D; GENETICS; METABOLISM;

ANIMALS; CELL LINE; ENTEROVIRUS D, HUMAN; HAPLOIDY; HUMANS; RECEPTORS, VIRUS;

EID: 84956699023     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1524498113     Document Type: Article

References (34)

1. Solomon T, et al. (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10 (11): 778-790.
2. Blomqvist S, Savolainen C, Raman L, Roivainen M, Hovi T (2002) Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J Clin Microbiol 40 (11): 4218-4223.
3. Schieble JH, Fox VL, Lennette EH (1967) A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol 85 (2): 297-310.
4. CDC (2011) Clusters of acute respiratory illness associated with human enterovirus 68- Asia, Europe, and United States, 2008-2010. MMWR 60 (38): 2008-2010.
5. Meijer A, et al. (2012) Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology 423 (1): 49-57.
6. Tokarz R, et al. (2012) Worldwide emergence of multiple clades of enterovirus 68. J Gen Virol 93 (Pt 9): 1952-1958.
7. Lauinger IL, et al. (2012) Lineages, sub-lineages and variants of enterovirus 68 in recent outbreaks. PLoS One 7 (4): e36005.
8. Messacar K, et al. (2015) A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet 385 (9978): 1662-1671.
9. Greninger AL, et al. (2015) A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): A retrospective cohort study. Lancet Infect Dis 15 (6): 671-682.
10. Bergelson JM, Coyne CB (2013) Picornavirus entry. Adv Exp Med Biol 790: 24-41.
11. Olson NH, et al. (1993) Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci USA 90 (2): 507-511.
12. Liu Y, et al. (2015) Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 347 (6217): 71-74.
13. Uncapher CR, DeWitt CM, Colonno RJ (1991) The major and minor group receptor families contain all but one human rhinovirus serotype. Virology 180 (2): 814-817.
14. Imamura T, et al. (2014) Antigenic and receptor binding properties of enterovirus 68. J Virol 88 (5): 2374-2384.
15. Carette JE, et al. (2011) Ebola virus entry requires the cholesterol transporter Niemann- Pick C1. Nature 477 (7364): 340-343.
16. Jae LT, et al. (2014) Virus entry. Lassa virus entry requires a trigger-induced receptor switch. Science 344 (6191): 1506-1510.
17. Carette JE, et al. (2009) Haploid genetic screens in human cells identify host factors used by pathogens. Science 326 (5957): 1231-1235.
18. Carette JE, et al. (2011) Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. Nat Biotechnol 29 (6): 542-546.
19. de Vries E, et al. (2012) Influenza A virus entry into cells lacking sialylated N-glycans. Proc Natl Acad Sci USA 109 (19): 7457-7462.
20. Stevenson RA, Huang J-A, Studdert MJ, Hartley CA (2004) Sialic acid acts as a receptor for equine rhinitis A virus binding and infection. J Gen Virol 85 (Pt 9): 2535-2543.
21. Shinya K, et al. (2006) Avian flu: Influenza virus receptors in the human airway. Nature 440 (7083): 435-436.
22. Nicholls JM, Bourne AJ, Chen H, Guan Y, Peiris JSM (2007) Sialic acid receptor detection in the human respiratory tract: Evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res 8: 73.
23. Wright PW, Strauss GH, Langford MP (1992) Acute hemorrhagic conjunctivitis. Am Fam Physician 45 (1): 173-178.
24. Kabue JP, et al. (2007) New enteroviruses, EV-93 and EV-94, associated with acute flaccid paralysis in the Democratic Republic of the Congo. J Med Virol 79 (4): 393-400.
25. Alexander DA, Dimock K (2002) Sialic acid functions in enterovirus 70 binding and infection. J Virol 76 (22): 11265-11272.
26. Liu Y, et al. (2015) Sialic acid-dependent cell entry of human enterovirus D68. Nat Commun 6: 8865.
27. Powell RM, et al. (1998) Characterization of echoviruses that bind decay accelerating factor (CD55): Evidence that some haemagglutinating strains use more than one cellular receptor. J Gen Virol 79 (Pt 7): 1707-1713.
28. Hu L, et al. (2012) Cell attachment protein VP8∗ of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature 485 (7397): 256-259.
29. Malakhov MP, et al. (2006) Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob Agents Chemother 50 (4): 1470-1479.
30. Rhoden E, Zhang M, Nix WA, Oberste MS (2015) In vitro efficacy of antiviral compounds against enterovirus D68. Antimicrob Agents Chemother 59 (12): 7779-7781.
31. Jae LT, et al. (2013) Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science 340 (6131): 479-483.
32. Dorobantu CM, et al. (2014) Recruitment of PI4KIIIβ to coxsackievirus B3 replication organelles is independent of ACBD3, GBF1, and Arf1. J Virol 88 (5): 2725-2736.
33. Belov GA, Fogg MH, Ehrenfeld E (2005) Poliovirus proteins induce membrane association of GTPase ADP-ribosylation factor. J Virol 79 (11): 7207-7216.
34. Lanke KHW, et al. (2009) GBF1, a guanine nucleotide exchange factor for Arf, is crucial for coxsackievirus B3 RNA replication. J Virol 83 (22): 11940-11949.